The negative pressure wound therapy market is estimated to be valued at US$ 6.5 billion in 2023. The market is expected to reach US$ 10.8 billion by 2033, developing at a CAGR of 5.3%.
Negative Pressure Wound Therapy Market Trend Analysis
| Attributes | Key Insights |
|---|---|
| Negative Pressure Wound Therapy Market Estimated Size in 2023 | US$ 6.5 billion |
| Projected Market Value in 2033 | US$ 10.8 billion |
| Value-based CAGR from 2023 to 2033 | 5.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
A study by our analysts found that a 3.5% CAGR was experienced between 2018 and 2022 in the driveline additive market. Global demand for negative pressure wound therapy is predicted to increase at a CAGR of 5.3% from 2023 to 2033.
Growth in the negative pressure wound therapy market is driven by the rising prevalence of chronic wounds worldwide, growing awareness about the benefits of NPWT, increasing need for better wound care to reduce mortality rate, and continuous NPWT product launches.
Negative wound pressure therapy is a non-invasive technique that uses sub-atmospheric pressure to aid in the management of chronic and acute open wounds. It has become one of the most effective treatments for the management of chronic wounds.
The increasing incidence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and post-surgical wounds is a major impetus to negative pressure wound therapy growth. According to the International Diabetes Federation (IDF), diabetic foot and lower limb complications affect around 40 to 60 million people with diabetes globally. This rise in the number of diabetic foot ulcers will continue to create opportunities for negative pressure wound therapy device manufacturers.
Various key players are offering NPWT devices for rent to make them more accessible and affordable for patients to manage their wound healing. This will further expand the global negative pressure wound therapy market size in the future.
| Historical CAGR from 2018 to 2022 | 3.5% |
|---|---|
| Forecast CAGR from 2023 to 2033 | 5.3% |
Principal Consultant
Future Market Insights has compared three markets, namely the advanced wound dressing market and digital wound measurement devices market are below. The negative pressure wound therapy market size is expected to dominate these three markets over the forecast period from 2023 to 2033.
Negative Pressure Wound Therapy Market:
| CAGR from 2023 to 2033 | 5.3% |
|---|---|
| Market Value in 2033 | US$ 10.8 billion |
| Key Trends |
|
| Opportunities |
|
Advance Wound Dressing Market:
| CAGR from 2023 to 2033 | 4.8% |
|---|---|
| Market Value in 2033 | US$ 16.2 billion |
| Key Trends |
|
| Opportunities |
|
Digital Wound Measurement Devices Market:
| CAGR from 2023 to 2033 | 3.8% |
|---|---|
| Market Value in 2033 | US$ 3293 million |
| Key Trends |
|
| Opportunities |
|
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below showcases revenues in the top 5 leading countries, spearheaded by the United States and the United Kingdom. Through 2033, these two countries are likely to dominate the market, with a combined size of US$ 8.6 billion and US$ 8.2 billion.
| Germany | US$ 7.4 billion |
|---|---|
| India | US$ 5.5 billion |
| The United States | US$ 8.6 billion |
| China | US$ 6.9 billion |
| The United Kingdom | US$ 8.2 billion |
| Germany | 5.0% |
|---|---|
| India | 4.8% |
| The United States | 5.2% |
| China | 4.9% |
| The United Kingdom | 5.1% |
Total sales of negative pressure wound therapy in the United States accounted for 86.9% of the North American market share in 2021 and are likely to grow at a steady pace during pace. Growth in the United States negative pressure wound therapy market is driven by the rising prevalence of diabetic and pressure ulcers, the highly developed healthcare industry, increasing expenditure on wound care, and the presence of leading NPWT device manufacturers.
Over the years, there has been a sharp rise in the cases of pressure ulcers across the United States. According to the Agency for Healthcare Research and Quality (AHRQ), more than 2.5 million people in the United States develop pressure ulcers each year.
As these pressure ulcers have high morbidity and mortality rates, people with these ulcers often opt for treatments like negative pressure treatment therapy. The rise in cases of pressure ulcers will, therefore continue to boost the growth of the negative pressure wound therapy market during the forecast period.
The United Kingdom will account for 35.7% of the negative pressure wound therapy market 2033. In 2033, the market is expected to grow by 5.1% year-on-year, reaching a valuation of US$ 8.2 billion by the end of 2033.
The growing popularity of home healthcare, expansion of the advanced wound dressing market, and increasing usage of digital wound measurement devices will positively impact the negative pressure wound therapy devices market outlook in the United Kingdom.
With the rising incidence of chronic wounds, flourishing medical tourism industry, increasing usage of NPWT dressings, and presence of advanced healthcare facilities, Germany's negative pressure wound therapy market is poised to exhibit strong growth during the forecast period. In 2023, Germany accounted for a share of 30.2% of the European negative pressure wound therapy (NPWT) market, and this number is expected to grow substantially during the forecast period.
The rising incidence of chronic wounds and increasing spending on wound care is a major factor driving the growth of the German negative pressure wound therapy market. According to a report published in the Journal of the European Wound Management Association (EWMA Journal), around 0.24% of the population in Germany is affected by chronic wounds.
Increasing adoption of wound debridement products, advancement in wound irrigation devices, and rapid growth of the negative pressure wound therapy devices market will create opportunities for the leading NPWT players in the country.
In 2021, China accounted for 56.0% of the East Asia negative pressure wound therapy market. Factors such as the increasing incidence of various chronic wounds like diabetic foot ulcers and pressure ulcers, and the availability of advanced NPWT devices at lower costs drive the market demand in China
Increasing government investments in expanding the healthcare industry and growing wound care spending are some of the factors driving growth in the China NPWT market.
According to market forecasts, the standalone NPWT devices segment is predicted to dominate until 2033, with a market share of 35.5%. The post-surgical ulcers & open wound segment is expected to have a share of 30.2.
| Category | Market share |
|---|---|
| Standalone NPWT Devices | 35.5% |
| post-surgical ulcers & open wound | 30.2% |
The global negative pressure wound therapy market is segmented based on product type into standalone NPWT devices, portable NPWT devices, single-use NPWT devices, NPWT dressings, and NPWT accessories. The standalone NPWT device segment sales accounted for the highest share of 35.5% in 2023 and are likely to grow further at 5.1% CAGR during the forecast period.
The growth of the segment is attributed to the rapid rise in the number of hospitals worldwide and the growing adoption of standalone NPWT devices across hospitals and ambulatory surgical centers due to high patient footfall.
The global negative pressure wound therapy market forecasts the single-use BPWT devices segment to grow considerably due to the growing health awareness among people and the rapid expansion of the disposable negative pressure wound therapy devices market across developed and developing regions.
Single-use negative pressure wound therapy devices have become a safe and effective alternative to traditional negative pressure wound therapy devices as they promote the healing of selected open wounds and reduce complication rates in closed surgical incisions.
According to Future Market Insights, the post-surgical ulcers & open wound segment will continue to dominate the global negative pressure wound therapy market, accounting for the largest share of 30.2% in 2023. The rising incidence of postoperative ulcers and wounds worldwide is driving this segmental growth.
Leading negative pressure wound therapy device manufacturers are increasingly focusing on expanding their product offerings to strengthen their customer base. Moreover, they are adopting growth strategies such as new product launches, partnerships, acquisitions, mergers, collaborations, etc. to expand their global footprint and gain a competitive edge in the global negative pressure wound therapy market. For instance,
| Attributes | Details |
|---|---|
| Estimated Market Size in 2023 | US$6.5 billion |
| Projected Market Valuation in 2033 | US$ 10.8 billion |
| Value-based CAGR 2023 to 2033 | 5.3% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | Value in US$ billion |
| Key Regions Covered |
|
| Key Market Segments Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
As of 2023, the market for negative pressure wound therapy is expected to be valued at US$ 6.5 billion.
By 2033, the market value of negative pressure wound therapy is expected to reach US$ 10.8 billion.
From 2023 to 2033, negative pressure wound therapy sales are expected to flourish at a CAGR of 5.3%
The standalone NPWT devices segment will account for a market share of 35.5% in 2023.
The United States is likely the top-performing market and is expected to account for a share of 86.9% by 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Standalone NPWT Devices 5.3.1.1. Product 5.3.1.2. Services 5.3.2. Portable NPWT Devices 5.3.2.1. Product 5.3.2.2. Services 5.3.3. Single-Use NPWT Devices 5.3.3.1. Product 5.3.3.2. Services 5.3.4. NPWT Dressings 5.3.4.1. Foam Dressings 5.3.4.2. Hydrocolloid Dressings 5.3.4.3. Standard Gauze Dressings 5.3.5. NPWT Accessories 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033 6.3.1. Diabetic Foot Ulcers 6.3.2. Pressure Ulcers 6.3.3. Venous Leg Ulcers 6.3.4. Post-Surgical Ulcers & Open Wound 6.3.5. Burn Wounds 6.3.6. Other Wounds 6.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-User, 2023 to 2033 7.3.1. Hospitals 7.3.1.1. Acute Care Centers 7.3.1.2. Community Hospitals 7.3.2. Ambulatory Surgical Centers 7.3.3. Trauma Care Centers 7.3.4. Specialty Clinics 7.3.5. Home Care Settings 7.3.6. Long-Term Care Centers 7.3.7. Skilled Nursing Facilities 7.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Indication 9.2.4. By End-User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Indication 9.3.4. By End-User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Indication 10.2.4. By End-User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Indication 10.3.4. By End-User 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product Type 11.2.3. By Indication 11.2.4. By End-User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Indication 11.3.4. By End-User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product Type 12.2.3. By Indication 12.2.4. By End-User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Indication 12.3.4. By End-User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product Type 13.2.3. By Indication 13.2.4. By End-User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Indication 13.3.4. By End-User 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product Type 14.2.3. By Indication 14.2.4. By End-User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Indication 14.3.4. By End-User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product Type 15.2.3. By Indication 15.2.4. By End-User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Indication 15.3.4. By End-User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product Type 16.1.2.2. By Indication 16.1.2.3. By End-User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product Type 16.2.2.2. By Indication 16.2.2.3. By End-User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product Type 16.3.2.2. By Indication 16.3.2.3. By End-User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product Type 16.4.2.2. By Indication 16.4.2.3. By End-User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product Type 16.5.2.2. By Indication 16.5.2.3. By End-User 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product Type 16.6.2.2. By Indication 16.6.2.3. By End-User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product Type 16.7.2.2. By Indication 16.7.2.3. By End-User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product Type 16.8.2.2. By Indication 16.8.2.3. By End-User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product Type 16.9.2.2. By Indication 16.9.2.3. By End-User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product Type 16.10.2.2. By Indication 16.10.2.3. By End-User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product Type 16.11.2.2. By Indication 16.11.2.3. By End-User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product Type 16.12.2.2. By Indication 16.12.2.3. By End-User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product Type 16.13.2.2. By Indication 16.13.2.3. By End-User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product Type 16.14.2.2. By Indication 16.14.2.3. By End-User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product Type 16.15.2.2. By Indication 16.15.2.3. By End-User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product Type 16.16.2.2. By Indication 16.16.2.3. By End-User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product Type 16.17.2.2. By Indication 16.17.2.3. By End-User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product Type 16.18.2.2. By Indication 16.18.2.3. By End-User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product Type 16.19.2.2. By Indication 16.19.2.3. By End-User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product Type 16.20.2.2. By Indication 16.20.2.3. By End-User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product Type 16.21.2.2. By Indication 16.21.2.3. By End-User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Product Type 16.22.2.2. By Indication 16.22.2.3. By End-User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Product Type 16.23.2.2. By Indication 16.23.2.3. By End-User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Indication 17.3.4. By End-User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Cardinal Health 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Mölnlycke Health Care 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Acelity L.P. Inc. (3M) 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Lohmann & Rauscher GmbH & Co. KG 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Smith & Nephew 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. ConvaTec Inc 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. DeRoyal Industries, Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. HARTMANN 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Medela LLC 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Haromed Bvba 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 18.1.11. Carilex Medical GmbH 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.11.5.2. Product Strategy 18.1.11.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Negative Pressure Wound Therapy Market
